UK Wedding News
05/12/2016
The initiative is between NHS England and Public Health England, and follows the recent Court of Appeal ruling that NHS England, alongside local authorities, has the power – but not the obligation – to fund the provision of anti-retroviral drugs for the prevention of HIV, known as pre-exposure prophylaxis (PrEP).
PrEP is a daily pill that disables HIV before it gets a stranglehold in the body. It costs £400 a month per person and trials suggest it can reduce the risk of being infected by up to 86%.
While NHS England has said there is "strong" evidence that the drug is effective, questions still need to be answered about how it is used on a wider scale.
It is understood the first phase of implementation will be the launch of a large scale clinical trial lasting over the next three years, and including at least 10,000 participants.
NHS England will fund the cost of the trial phase and will work in partnership with local authorities, the Local Government Association and Public Health England to implement the findings as part of a wider national rollout. Up to £10 million will be made available to fund all aspects of the trial.
Dr Jonathan Fielden, Director of Specialised Commissioning and Deputy National Medical Director, NHS England said: "We're pleased to be able to announce funding not only for ten new specialised treatments but also a new ground breaking national programme for PrEP that will benefit at least 10,000 people.
"This has, in part, been made possible by the willingness of many pharmaceutical and device companies to come forward with lower and more responsible prices. Continuing this constructive joint working will enable us to fund more new drugs and treatments in the future.
"We have however, had to make some tough decisions over what we are not able to fund at this point in time within the resources we have available. We will ensure those treatments have the opportunity to be considered as part of the next annual prioritisation round in spring 2017."
Professor Kevin Fenton, Director of Health and Wellbeing at Public Health England, added: "Currently 13,500 people are living in the UK with undiagnosed HIV and we are still seeing around 5,000 new infections each year. Given we are in the fourth decade of this epidemic there are too many new infections occurring, and we need to use all tools available to save lives and money.
"We're delighted to be working in partnership with NHS England on this major new addition to the national HIV prevention programme. This comes after much planning and preparation to ensure we can successfully coordinate this extremely important and large scale clinical trial."
NHS England also confirmed it is to routinely commission 10 new specialised treatments as part of its prioritisation process for specialised treatments. The decision is based on advice from NHS England's clinical priorities advisory group which assessed the relative priority of investing in a new range of specialised treatments and interventions.
(JP/LM)
20/03/2020
LeToya Luckett-Walker Is Pregnant
Charlotte Crosby Finds New Romance
Lydia Bright Gets Candid About Giving Birth
Lana Del Ray Splits From Boyfriend
Angelica Ross Learns Of Boyfriend's Secret Life
Ashley Graham's Breastfeeding Struggle
Susanna Reid's Mother's Day Plans
Lin-Manuel Miranda Homeschooling Kids
Kristen Bell Speaks Of Pride For Daughters
Prince George & Princess Charlotte Now Homeschooled
NHS England To Offer HIV Drug Treatment
NHS England has announced that it is to fund an extension to the HIV prevention programme led by Public Health England.The initiative is between NHS England and Public Health England, and follows the recent Court of Appeal ruling that NHS England, alongside local authorities, has the power – but not the obligation – to fund the provision of anti-retroviral drugs for the prevention of HIV, known as pre-exposure prophylaxis (PrEP).
PrEP is a daily pill that disables HIV before it gets a stranglehold in the body. It costs £400 a month per person and trials suggest it can reduce the risk of being infected by up to 86%.
While NHS England has said there is "strong" evidence that the drug is effective, questions still need to be answered about how it is used on a wider scale.
It is understood the first phase of implementation will be the launch of a large scale clinical trial lasting over the next three years, and including at least 10,000 participants.
NHS England will fund the cost of the trial phase and will work in partnership with local authorities, the Local Government Association and Public Health England to implement the findings as part of a wider national rollout. Up to £10 million will be made available to fund all aspects of the trial.
- - - - - - Advertisement - - - - - -
Dr Jonathan Fielden, Director of Specialised Commissioning and Deputy National Medical Director, NHS England said: "We're pleased to be able to announce funding not only for ten new specialised treatments but also a new ground breaking national programme for PrEP that will benefit at least 10,000 people.
"This has, in part, been made possible by the willingness of many pharmaceutical and device companies to come forward with lower and more responsible prices. Continuing this constructive joint working will enable us to fund more new drugs and treatments in the future.
"We have however, had to make some tough decisions over what we are not able to fund at this point in time within the resources we have available. We will ensure those treatments have the opportunity to be considered as part of the next annual prioritisation round in spring 2017."
Professor Kevin Fenton, Director of Health and Wellbeing at Public Health England, added: "Currently 13,500 people are living in the UK with undiagnosed HIV and we are still seeing around 5,000 new infections each year. Given we are in the fourth decade of this epidemic there are too many new infections occurring, and we need to use all tools available to save lives and money.
"We're delighted to be working in partnership with NHS England on this major new addition to the national HIV prevention programme. This comes after much planning and preparation to ensure we can successfully coordinate this extremely important and large scale clinical trial."
NHS England also confirmed it is to routinely commission 10 new specialised treatments as part of its prioritisation process for specialised treatments. The decision is based on advice from NHS England's clinical priorities advisory group which assessed the relative priority of investing in a new range of specialised treatments and interventions.
(JP/LM)
Top stories
20/03/2020
LeToya Luckett-Walker Is Pregnant
Charlotte Crosby Finds New Romance
Lydia Bright Gets Candid About Giving Birth
Lana Del Ray Splits From Boyfriend
Angelica Ross Learns Of Boyfriend's Secret Life
Ashley Graham's Breastfeeding Struggle
Susanna Reid's Mother's Day Plans
Lin-Manuel Miranda Homeschooling Kids
Kristen Bell Speaks Of Pride For Daughters
Prince George & Princess Charlotte Now Homeschooled
